Industries, particularly high tech, may be waiting for the U.S. Supreme Court decision, expected this coming spring, in the Bilski case to decide some fundamental questions of when you can patent ...
A unanimous U.S. Supreme Court ruling Monday backed away from a decades-old legal test that high-tech firms argue has sparked an abundance of obvious patents. In a hotly anticipated decision that ...
Business method patents have been a contentious issue, with some saying that they're necessary for software innovation and others claiming that they prevent innovation. The Bilski case, which will be ...
“[O]ur elimination of the rigid Rosen-Durling test is compelled by both the statute and Supreme Court precedent.” – CAFC opinion But in June 2023, the court granted an increasingly rare en banc review ...
LKQ Corp. v. GM Global Technology Operations LLC has brought attention to the ongoing debate surrounding design patent law, particularly with respect to the Rosen-Durling test for design patent ...
A new method for evaluating hearing has received a second patent by the U.S. Patent and Trademark Office. Work leading to the patent, “Method for Determining Hearing Thresholds in the Absence of ...
This week, the Supreme Court announced that “reverse payment” settlements of patent litigation between branded and generic pharmaceutical companies are, when challenged in a subsequent antitrust case, ...
An American firm’s new European patent on a screening test for a genetic mutation that causes breast cancer has created an uproar among geneticists in Israel and Europe, who say the patent raises ...
A new method for evaluating hearing has received a second patent by the U.S. Patent and Trademark Office. Work leading to the patent, “Method for Determining Hearing Thresholds in the Absence of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback